Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market By Product Type (AMG-228, BMS-986156) And By End-Users/Application (Melanoma, Non-Small Cell Lung Cancer) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

According to Apex Market Research the Tumor Necrosis Factor Receptor Superfamily Member 18 market was valued at USD xx.xx million in 2019 and is anticipated to grow at a CAGR of xx% during the forecast period from 2020 to 2028. The report on Tumor Necrosis Factor Receptor Superfamily Member 18 market delivers detailed analysis covering major regional trends, market dynamics, and offer country-level market value of Tumor Necrosis Factor Receptor Superfamily Member 18 industry. Some of the major aspects considered during the course of research comprises definition of the product, classification of the product, industry structure, different participants in the Tumor Necrosis Factor Receptor Superfamily Member 18 ecosystem, etc. The report comprises of market value and forecast for the period from 2020 to 2028, CAGR measured for individual segment and regional market, competitive landscape of key market players, and profiling of major providers participating in the Tumor Necrosis Factor Receptor Superfamily Member 18 market.

The following manufacturers are covered in this report:
  • Ablynx NV
  • Amgen Inc
  • Apogenix GmbH
  • Bristol-Myers Squibb Company
  • Five Prime Therapeutics Inc
  • Incyte Corp
  • MedImmune LLC
  • Merck & Co Inc
  • Novartis AG
  • OncoMed Pharmaceuticals Inc
  • Regeneron Pharmaceuticals Inc

The report estimates on the Tumor Necrosis Factor Receptor Superfamily Member 18 market economy trend, market numbers (Mn/Bn USD) and CAGR from the 2020-2028, considering 2019 as the base year. A global Tumor Necrosis Factor Receptor Superfamily Member 18 market report consist of all leading industry players, Tumor Necrosis Factor Receptor Superfamily Member 18 business sections, company profile, revenue supply by Tumor Necrosis Factor Receptor Superfamily Member 18 industry sections, global Tumor Necrosis Factor Receptor Superfamily Member 18 market trends, acquisitions and arrangements, contact info, recent development, geographic examination and even more using the assistance.

Since the onset of COVID-19 in December 2019, the governments of various countries declared lockdown and as result numerous economies around the world experienced severe economic downturn. Since early 2020, the Tumor Necrosis Factor Receptor Superfamily Member 18 market witnessed the impact of COVID-19 The report objects to provide pre-COVID-19 state of the Tumor Necrosis Factor Receptor Superfamily Member 18 market in years 2020 and 2019 and moreover it offers forecast for the Covid-19 period from 2020 to 2028.The report provides COVID-19 impact on Tumor Necrosis Factor Receptor Superfamily Member 18 market, global analysis, different challenges or threats and opportunities for stakeholders involved in the Tumor Necrosis Factor Receptor Superfamily Member 18 market.

Report Opportunity: Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market

This report delivers an analytical examination of the Tumor Necrosis Factor Receptor Superfamily Member 18 market summarized in broad sections such as
  1. Tumor Necrosis Factor Receptor Superfamily Member 18 Market Summary
  2. Key Commercial Growths in the Tumor Necrosis Factor Receptor Superfamily Member 18 Industry
  3. Market Dynamics Affecting the Tumor Necrosis Factor Receptor Superfamily Member 18 Industry
  4. Important Market Trends and Future Development Scenario of the Tumor Necrosis Factor Receptor Superfamily Member 18 Market
  5. Tumor Necrosis Factor Receptor Superfamily Member 18 Market Revenue and Forecast, by Type, 2018 – 2028
  6. Competitive Landscape of Tumor Necrosis Factor Receptor Superfamily Member 18 Industry
  7. Positioning of Main Market Players in the Tumor Necrosis Factor Receptor Superfamily Member 18 Industry
  8. Tumor Necrosis Factor Receptor Superfamily Member 18 Market Revenue and Forecast, by Application, 2018 - 2028
  9. Tumor Necrosis Factor Receptor Superfamily Member 18 Market Revenue and Forecast, by End-use, 2018 - 2028
  10. Tumor Necrosis Factor Receptor Superfamily Member 18 Market Revenue and Forecast, by Geography, 2018 - 2028
Tumor Necrosis Factor Receptor Superfamily Member 18 Market Segmentation:

The report provides detailed examination of the Tumor Necrosis Factor Receptor Superfamily Member 18 market on the basis of various segments such as type, application and end-use industry. The Tumor Necrosis Factor Receptor Superfamily Member 18 market is segmented as follows:

Tumor Necrosis Factor Receptor Superfamily Member 18 Market, by Type:
  • AMG-228
  • BMS-986156
  • FPA-154
  • GWN-323
  • INCAGN-1876
  • Others
Tumor Necrosis Factor Receptor Superfamily Member 18 Market, by Application:
  • Melanoma
  • Non-Small Cell Lung Cancer
  • Gastric Cancer
  • Blood Cancer
  • Others
Geographic Coverage

The report on the Tumor Necrosis Factor Receptor Superfamily Member 18 market delivers an in depth country-level cross-sectional analysis across different regions around the globe. The report comprises of complete market value and forecast for the following countries and regions:

North America Tumor Necrosis Factor Receptor Superfamily Member 18 Market Revenue and Forecast
  • U.S.
  • Canada
Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Market Revenue and Forecast
  • UK
  • Germany
  • France
  • Rest of Europe
Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Market Revenue and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Market Revenue and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Market Revenue and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Snapshot
          2.1.1. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market By Type,2019
               2.1.1.1.AMG-228
               2.1.1.2.BMS-986156
               2.1.1.3.FPA-154
               2.1.1.4.GWN-323
               2.1.1.5.INCAGN-1876
               2.1.1.6.Others
          2.1.2. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market By Application,2019
               2.1.2.1.Melanoma
               2.1.2.2.Non-Small Cell Lung Cancer
               2.1.2.3.Gastric Cancer
               2.1.2.4.Blood Cancer
               2.1.2.5.Others
          2.1.3. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market By End-use,2019
          2.1.4. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market By Geography,2019

3. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size (US$), By Type, 2018 – 2028

5. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size (US$), By Application, 2018 – 2028

6. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size (US$), By End-use, 2018 – 2028

7. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Tumor Necrosis Factor Receptor Superfamily Member 18 Market Analysis, 2018 – 2028 
          7.2.1. North America Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Market Analysis, 2018 – 2028 
          7.3.1.  Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Tumor Necrosis Factor Receptor Superfamily Member 18 Market Analysis, 2018 – 2028 
          7.6.1.  MEA Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Tumor Necrosis Factor Receptor Superfamily Member 18 Providers
        8.4.1 Ablynx NV
                8.1.1 Business Description
                8.1.2 Ablynx NV Geographic Operations
                8.1.3 Ablynx NV Financial Information
                8.1.4 Ablynx NV Product Positions/Portfolio
                8.1.5 Ablynx NV Key Developments
        8.4.2 Amgen Inc
                8.2.1 Business Description
                8.2.2 Amgen Inc Geographic Operations
                8.2.3 Amgen Inc Financial Information
                8.2.4 Amgen Inc Product Positions/Portfolio
                8.2.5 Amgen Inc Key Developments
        8.4.3 Apogenix GmbH
                8.3.1 Business Description
                8.3.2 Apogenix GmbH Geographic Operations
                8.3.3 Apogenix GmbH Financial Information
                8.3.4 Apogenix GmbH Product Positions/Portfolio
                8.3.5 Apogenix GmbH Key Developments
        8.4.4 Bristol-Myers Squibb Company
                8.4.1 Business Description
                8.4.2 Bristol-Myers Squibb Company Geographic Operations
                8.4.3 Bristol-Myers Squibb Company Financial Information
                8.4.4 Bristol-Myers Squibb Company Product Positions/Portfolio
                8.4.5 Bristol-Myers Squibb Company Key Developments
        8.4.5 Five Prime Therapeutics Inc
                8.5.1 Business Description
                8.5.2 Five Prime Therapeutics Inc Geographic Operations
                8.5.3 Five Prime Therapeutics Inc Financial Information
                8.5.4 Five Prime Therapeutics Inc Product Positions/Portfolio
                8.5.5 Five Prime Therapeutics Inc Key Developments
        8.4.6 Incyte Corp
                8.6.1 Business Description
                8.6.2 Incyte Corp Geographic Operations
                8.6.3 Incyte Corp Financial Information
                8.6.4 Incyte Corp Product Positions/Portfolio
                8.6.5 Incyte Corp Key Developments
        8.4.7 MedImmune LLC
                8.7.1 Business Description
                8.7.2 MedImmune LLC Geographic Operations
                8.7.3 MedImmune LLC Financial Information
                8.7.4 MedImmune LLC Product Positions/Portfolio
                8.7.5 MedImmune LLC Key Developments
        8.4.8 Merck & Co Inc
                8.8.1 Business Description
                8.8.2 Merck & Co Inc Geographic Operations
                8.8.3 Merck & Co Inc Financial Information
                8.8.4 Merck & Co Inc Product Positions/Portfolio
                8.8.5 Merck & Co Inc Key Developments
        8.4.9 Novartis AG
                8.9.1 Business Description
                8.9.2 Novartis AG Geographic Operations
                8.9.3 Novartis AG Financial Information
                8.9.4 Novartis AG Product Positions/Portfolio
                8.9.5 Novartis AG Key Developments
        8.4.10 OncoMed Pharmaceuticals Inc
                8.10.1 Business Description
                8.10.2 OncoMed Pharmaceuticals Inc Geographic Operations
                8.10.3 OncoMed Pharmaceuticals Inc Financial Information
                8.10.4 OncoMed Pharmaceuticals Inc Product Positions/Portfolio
                8.10.5 OncoMed Pharmaceuticals Inc Key Developments
        8.4.11 Regeneron Pharmaceuticals Inc
                8.11.1 Business Description
                8.11.2 Regeneron Pharmaceuticals Inc Geographic Operations
                8.11.3 Regeneron Pharmaceuticals Inc Financial Information
                8.11.4 Regeneron Pharmaceuticals Inc Product Positions/Portfolio
                8.11.5 Regeneron Pharmaceuticals Inc Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Tumor Necrosis Factor Receptor Superfamily Member 18 Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Tumor Necrosis Factor Receptor Superfamily Member 18 Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Tumor Necrosis Factor Receptor Superfamily Member 18 Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Tumor Necrosis Factor Receptor Superfamily Member 18 Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Tumor Necrosis Factor Receptor Superfamily Member 18 Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Tumor Necrosis Factor Receptor Superfamily Member 18 Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Tumor Necrosis Factor Receptor Superfamily Member 18: Market Segmentation 
FIG. 2 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Tumor Necrosis Factor Receptor Superfamily Member 18 Providers, 2019
FIG. 11 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Tumor Necrosis Factor Receptor Superfamily Member 18 Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Tumor Necrosis Factor Receptor Superfamily Member 18 Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Tumor Necrosis Factor Receptor Superfamily Member 18 market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 
2038

2118

OUR CLIENT